Pattern and persistence of the epitope-specific IgM response against human cytomegalovirus in renal transplant patients

Journal of Clinical Virology

Volumn 24, Issue 1-2, 2002, Pages 45-56

  Müller, Thomas F ^a,c   Gicklhorn, Dorothee ^b   Jungraithmayr, Therese ^a   Eickmann, Markus ^b   Lange, Harald ^a   Radsak, Klaus ^b   Reschke, Marko ^b  

^a Clinic of Nephrology   (Germany)

^b Institute of Virology   (Germany)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

CMV infection; Compromised immune system; IgM persistence; Western blotting

Indexed keywords

EPITOPE; GLYCOPROTEIN B; GLYCOPROTEIN H; IMMUNOGLOBULIN M; PROTEIN; PROTEIN PP150; PROTEIN PP65; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANTIBODY DETECTION; ANTIBODY RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMODIALYSIS PATIENT; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE DEFICIENCY; IMMUNOREACTIVITY; INTEGUMENT; KIDNEY GRAFT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; WESTERN BLOTTING;

ANTIBODIES, VIRAL; BLOTTING, WESTERN; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPITOPES; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN M; KIDNEY TRANSPLANTATION; PHOSPHOPROTEINS; RECOMBINANT PROTEINS; RENAL DIALYSIS; VIRAL ENVELOPE PROTEINS; VIRAL MATRIX PROTEINS;

EID: 0036138571     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(01)00228-1     Document Type: Conference Paper

References (45)

1. Viral mechanisms of immune evasion
2. Lessons from the natural history of cytomegalovirus
3. Cytomegalovirus in renal transplantation
4. Pathogenicity: Animal models
5. Die beurteilung des diagnostischen wertes klinisch-chemischer untersuchungen (Evaluation of the diagnostic value of laboratory investigations)
6. Implication of γδ T cells in the human immune response to cytomegalovirus
7. Congenital cytomegalovirus infection
8. Uremic serum effects on peripheral blood mononuclear cells and purified T lymphocyte responses
9. Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy
10. Long-term persistence of immunoglobulin A (IgA) and IgM antibodies against human cytomegalovirus in solid-organ transplant recipients
11. Antigenemia, immunoblotting, and enzyme immunoassay for early diagnosis of cytomegalovirus infection in renal transplant patients
12. Infection in organ transplant recipients
13. Longitudinal study of cytomegalovirus antibodies in individuals infected with the human immunodeficiency virus
14. Direct evidence that gamma 1 and gamma 3 switching in human B cells is interleukin-10 dependent
15. Immunoblot analysis of the humoral immune response in primary cytomegalovirus infection
16. Limitations of cytomegalovirus testing
17. Cytomegalovirus disease recurrence after Ganciclovir treatment in kidney and kidney-pancreas transplant recipients
18. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus
19. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10)
20. IgM antibody detection of ppUL80a and ppUL32 by immunoblotting: An early parameter for recurrent cytomegalovirus infection in renal transplant recipients
21. CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: Expansion of an uncommon CD8+CD57- subset and its progressive replacement by CD8+CD57+ T cells
22. A novel Western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M detection
23. Development of a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot for detection of CMV-specific IgM
24. Emergence of Ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants
25. Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer
26. Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naïve B lymphocytes
27. An enzyme labelled nuclear antigen immunoassay for detection of cytomegalovirus IgM antibodies in human serum: Specific and non specific reactions
28. Cytomegalovirus-specific antibody responses in renal transplant patients with primary and recurrent CMV infections
29. Cytomegaloviurs vaccine
30. Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus
31. Temporal pattern of immunoblot-reactive antibodies to cytomegalovirus in transplant recipients
32. CD8-positive T lymphocyte specific for murine cytomegalovirus immediate-early antigens mediate protective immunity
33. Constitutive expression of human cytomegalovirus (HCMV) glycoprotein gpUL75 in astrocytoma cells: A study of the specific humoral immune response
34. Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load
35. Impaired function of macrophage Fcγ receptors in end-stage renal disease
36. Cytomegalovirus infection in renal transplant recipients
37. The humoral immune response against human cytomegalovirus is characterised by a delayed synthesis of glycoprotein-specific antibodies
38. Kinetics of the antibody response against human cytomegalovirus-specific proteins in allogeneic bone marrow transplant recipients
39. The human cytomegalovirus glycoprotein B gene (ORF UL55) is expressed early in the infectious cycle
40. Pentoxifylline promotes replication of human cytomegalovirus in vivo and in vitro
41. Ureamia and host defenses
42. Proliferative T cell responses to four human cytomegalovirus-specific proteins in healthy subjects and solid organ transplant recipients
43. Neutralizing antibody response against human cytomegalovirus in allogeneic bone marrow-transplant recipients
44. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
45. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice